Indirubin-3'-<wbr/>monoxime

Indirubin-3′-monoxime

CAT N°: 13314
Price:

From 72.00 61.20

Indirubin-3’-oxime is a potent inhibitor of glycogen synthase kinase 3? (GSK3?; IC50 = 22 nM).{14994} As GSK3? phosphorylates tau protein, indirubin-3’-oxime prevents tau phosphorylation both in vitro and in vivo at Alzheimer’s disease-relevant sites.{14994} It also inhibits cyclin-dependent kinases (CDKs) at higher concentrations, including Cdk1/cyclin B (IC50 = 180 nM), Cdk2/cyclin A (IC50 ~500 nM), Cdk2/cyclin E (IC50 = 250nM), Cdk4/cyclin D1 (IC50 = 3.3 µM) and Cdk5/p35 (IC50 = 100 nM). Indirubin-3’-oxime reversibly inhibits the proliferation of many cells types, arresting cycling in the G2/M phase.{17246,17247}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one
  • Correlated keywords
    • glycogen synthase kinase-3? GSK-3? tau proteins Alzheimer’s diseases cyclin-dependent kinases CDK Cdk1 cyclin A B E D1 Cdk4 Cdk2 Cdk5 p35 growth proliferation synchronization cells arrest G2/M phases phosphorylation inhibits inhibition inhibitors
  • Product Overview:
    Indirubin-3’-oxime is a potent inhibitor of glycogen synthase kinase 3? (GSK3?; IC50 = 22 nM).{14994} As GSK3? phosphorylates tau protein, indirubin-3’-oxime prevents tau phosphorylation both in vitro and in vivo at Alzheimer’s disease-relevant sites.{14994} It also inhibits cyclin-dependent kinases (CDKs) at higher concentrations, including Cdk1/cyclin B (IC50 = 180 nM), Cdk2/cyclin A (IC50 ~500 nM), Cdk2/cyclin E (IC50 = 250nM), Cdk4/cyclin D1 (IC50 = 3.3 µM) and Cdk5/p35 (IC50 = 100 nM). Indirubin-3’-oxime reversibly inhibits the proliferation of many cells types, arresting cycling in the G2/M phase.{17246,17247}

We also advise you